Skip to Content

GP 122 (Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg)

Pill with imprint GP 122 is Yellow, Round and has been identified as Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; coronary artery disease; heart failure (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GP 122

Hydrochlorothiazide and Lisinopril

Imprint:
GP 122
Strength:
12.5 mg / 20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide